NRF2-driven metabolic reprogramming supports anabolic processes and survival under nutrient limitation, and NRF2 addiction in tumours may promote tumour cell proliferation, metastasis, and poor prognosis. The gene discussed is NFE2L2; the disease is neoplasm.